nifedipine has been researched along with epanolol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Blake, P; Lewis, JA | 1 |
| Berry, SC; Blake, P; Godley, M; Ratcliffe, M; Readman, A | 1 |
| Duncker, DJ; Gho, BC; McFalls, EO; Sassen, LM; Verdouw, PD | 1 |
| Readman, AS | 1 |
| Alberti, KG; Boon, NA; MacGregor, IR; Perrie, AM; Riemersma, RA; Stenhouse, F; Wright, RA | 1 |
3 trial(s) available for nifedipine and epanolol
| Article | Year |
|---|---|
A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Clinical Protocols; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Patient Satisfaction; Propanolamines; Quality of Life | 1991 |
Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Double-Blind Method; Drug Tolerance; Female; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nifedipine; Nitroglycerin; Propanolamines; Randomized Controlled Trials as Topic | 1989 |
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Glucose; Blood Pressure; Double-Blind Method; Humans; Insulin; Lipids; Male; Metoprolol; Nifedipine; Plasminogen Activator Inhibitor 1; Propanolamines; Risk Factors; Tissue Plasminogen Activator | 1994 |
4 other study(ies) available for nifedipine and epanolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Epanolol as a model for assessing patient preference in anti-anginal drug therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Choice Behavior; Female; Humans; Male; Metoprolol; Middle Aged; Models, Biological; Nifedipine; Patient Compliance; Propanolamines; Quality of Life | 1992 |
Effect of antiischemic therapy on coronary flow reserve and the pressure-maximal coronary flow relationship in anesthetized swine.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Benzeneacetamides; Blood Pressure; Coronary Circulation; Coronary Disease; Heart Rate; Metoprolol; Nifedipine; Propanolamines; Swine | 1991 |